Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
Month: May 2011
Retina Implant AG Presents Preliminary Results Of Permanently Implanted Patients At The ARVO Annual Meeting
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial. Results showed that the first seven patients who were permanently implanted …
SAR 1118 Demonstrates Encouraging Results In Phase 2 Study Of Dry Eye Disease
SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related fun…
Second Sight Announces Significant Results From The Argus? II Retinal Prosthesis Trial At The ARVO 2011 Annual Meeting
Exciting results from the Argus? II Retinal Prosthesis System (‘Argus II’) clinical trial were presented today at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) 2011 Annual Meeting. The clinical trial included 30 subjects implant…
Paulig Eye Surgery Centre First To Offer Innovative Keratoconus Treatment In Germany
The Paulig Eye Surgery Centre announces today that it has acquired advanced technology for performing Keraflex KXL, a new, non-invasive, non-surgical treatment for keratoconus. Surgeons at the Paulig Eye Surgery Centre will immediately begin treating p…
Retina Implant’s second clinical trial initial findings presented at ARVO 2011
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial.
Positive Ellex 2RT Data Demonstrates Efficacy In Treatment Of Early AMD
Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic technology, today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RT™) for the treatment of Early Age-Related Macular Degeneration (A…
Genetic Clue To ‘Emergency’ Glaucoma
Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma (ACG). The gene’s activity points to previously unsuspected mechanisms inv…
Bioptigen Offers Deep Imaging SDOCT For Pre-Clinical Applications
The medical imaging device company, Bioptigen Inc., has created the commercial market’s deepest spectral domain optical coherence tomography (SDOCT) imaging system for pre-clinical applications. Called the Envisu R4300, it is the first Fourier-domain O…
LCA-Vision Announces Management Promotion
LCA-Vision Inc. , a leading provider of laser vision correction services under the LasikPlus® brand, announces the promotion of Marcello J. Celentano to the newly created position of Senior Vice President of Operations, effective May 1, 2011. In his n…
Merck’s Phase III study shows efficacy results of tafluprost to treat ocular hypertension
Merck, known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ocular hypertension, who were dosed once-daily with tafluprost, Merck’s investigational, preservative-fre…
Merck’s Investigational Prostaglandin Analogue Ophthalmic Medication Tafluprost Meets Primary Endpoint In Phase III Study
WHITEHOUSE STATION, N.J., May 2, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ocular hypertension, who were dosed once-daily with t…
IRIDEX Granted U.S. Patent For Stepped Angled Laser Handpieces Used In Eye Surgery
MOUNTAIN VIEW, Calif., May 2, 2011 — IRIDEX Corporation (Nasdaq: IRIX) today
announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent
applying to a group of specially designed laser handpieces used in invasive ophthalmic
surgi…
Higher BMI In Children Associated With More Rapid Progression Of Diabetic Retinopathy
Overweight or obese children with type 1 diabetes developed diabetic retinopathy more quickly than their leaner counterparts, according to a poster here.
Positive Ellex 2RT Data Demonstrates Efficacy In Treatment Of Early AMD
Adelaide, Australia, 3 May 2011 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic technology, today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RTT) for the treatment of Early Age…
Vision Is in the Mouth of the Beholder With Adaptive Device
Coupling a sensor array placed in the mouth with a video camera lets the blind “see” obstacles with their tongues. Medscape Medical News
ARVO: Two-Year Safety Equal in AMD Drug Trial
FORT LAUDERDALE (MedPage Today) — Preliminary two-year safety data from the landmark CATT trial of ranibizumab (Lucentis) and bevacizumab (Avastin) for macular degeneration partially reversed conclusions from the one-year results reported last week, s…
ARVO announces 2011 award recipients in retinal research
The Association for Research in Vision and Ophthalmology is pleased to announce its 2011 ARVO Award recipients. These award recipients will be acknowledged at the ARVO 2011 Annual Meeting, May 1 – 5, in Fort Lauderdale, Fla.
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
Status: Active, not recruiting,
Condition Summary: Spinal Cord Diseases; Spinal Cord Injuries; Neuralgia; Pain
5 QUESTIONS WITH ROBERT GRANT
h4How did you come to pursue a career in the ophthalmic industry?/h4
I joined the ophthalmic industry in the early 1990s when I was appointed as the Asia-Pacific sales and marketing manager of HGM Medical Lasers in Salt Lake City. I recall at…